tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gregory Fraser, 44 are a BUY (91.67%), 4 are a HOLD (8.33%).
Analyst Gregory Fraser, carries an average stock price target met ratio of 38.35% that have a potential upside of 47.84% achieved within 112 days.
Gregory Fraser’s has documented 97 price targets and ratings displayed on 14 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ANIP, ANI Pharmaceuticals at 01-Mar-2024.
Analyst best performing recommendations are on EOLS (EVOLUS).
The best stock recommendation documented was for EOLS (EVOLUS) at 1/20/2022. The price target of $11 was fulfilled within 56 days with a profit of $5.46 (98.56%) receiving and performance score of 17.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2 years 4 months 29 days ago
(23-Aug-2022)
0/1 (0%)
$8.35 (228.77%)
Hold
$13
2 years 4 months 30 days ago
(22-Aug-2022)
0/1 (0%)
$8.7 (202.33%)
Buy
$10
2 years 8 months 4 days ago
(17-May-2022)
0/1 (0%)
$4.78 (91.57%)
Buy
$12
2 years 9 months 10 days ago
(11-Apr-2022)
0/1 (0%)
$3.91 (48.33%)
Buy
$20
2 years 9 months 10 days ago
(11-Apr-2022)
0/1 (0%)
$11.91 (147.22%)
What Year was the first public recommendation made by Gregory Fraser?
